Bank Of Montreal Annexon, Inc. Transaction History

Bank Of Montreal

$214 Billion
Q3 2024

A detailed history of Bank Of Montreal transactions in Annexon, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 151,463 shares of ANNX stock, worth $798,210. This represents 0.0% of its overall portfolio holdings.

Number of Shares

151,463

Holding current value

$798,210

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 13, 2024	BUY	$4.49 - $7.2 $680,068 - $1.09 Million	151,463 New	151,463 $896,000
Q4 2022 Feb 01, 2023	BUY	$4.56 - $6.61 $298,132 - $432,161	65,380 New	65,380 $338,000

Others Institutions Holding ANNX

# of Institutions

146

Shares Held

102M

Call Options Held

178K

Put Options Held

159K

Bain Capital Life Sciences Investors, LLC Boston, MA

8.45M
Shares

$44.5 Million
8.98% of portfolio
Satter Management Co., L.P.

7.41M
Shares

$39 Million
76.44% of portfolio
Bvf Inc San Francisco, CA

7M
Shares

$36.9 Million
1.32% of portfolio
Black Rock Inc. New York, NY

6.59M
Shares

$34.7 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

6.43M
Shares

$33.9 Million
2.49% of portfolio

View Full List

About Annexon, Inc.

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $251M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

More about ANNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account